Bruker Slides as No Fresh Catalyst Emerges and Broader Risk-Off Mood Weighs

Bruker Corporation (BRKR) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The catalyst is not entirely clear, but the move appears tied to a mix of company-specific overhangs and a weaker backdrop for growth-oriented stocks. This could be because investors are still digesting Bruker’s large goodwill impairment and negative free cash flow from its latest quarterly report, while rising Treasury yields have been pressuring equities more broadly.

Details:

Bruker’s most recent quarterly update showed a $134.9 million non-cash goodwill impairment charge, which pushed the company to a GAAP operating loss for the quarter.

The same report showed non-GAAP free cash flow was negative in the second quarter, a metric that can keep pressure on sentiment even when revenue and adjusted earnings improve.

Management updated full-year 2026 guidance only for currency and tax items, rather than lifting its core outlook, which may have limited bullish follow-through after earnings.

There does not appear to be a fresh negative company announcement today; Bruker’s recent public updates have centered on product and workflow launches, suggesting the decline may reflect market-driven selling as yields rise.

Sources:

Bruker, SEC, MarketScreener

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BRKR Insider Trading Activity

$BRKR insiders have traded $BRKR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $BRKR stock by insiders over the last 6 months:

MARK MUNCH (EXEC VP&PRES BRUKER NANO INC.) has made 0 purchases and 4 sales selling 8,000 shares for an estimated $415,560.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$BRKR Hedge Fund Activity

We have seen 231 institutional investors add shares of $BRKR stock to their portfolio, and 156 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 4,135,622 shares (+25.7%) to their portfolio in Q2 2026, for an estimated $248,881,731
SACHEM HEAD CAPITAL MANAGEMENT LP added 2,915,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $175,424,700
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,056,757 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $123,775,636
MILLENNIUM MANAGEMENT LLC removed 1,485,089 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $89,372,656
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,399,125 shares (+inf%) to their portfolio in Q2 2026, for an estimated $84,199,342
SCULPTOR CAPITAL LP added 1,355,000 shares (+41.4%) to their portfolio in Q2 2026, for an estimated $81,543,900
AQR CAPITAL MANAGEMENT LLC added 1,219,807 shares (+94.3%) to their portfolio in Q2 2026, for an estimated $73,407,985

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$BRKR Government Contracts

We have seen $13,339,348 of award payments to $BRKR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

ORDER FOR SUPPORT OF IPDS-LR SYSTEM: $1,261,366

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$BRKR Price Targets

Multiple analysts have issued price targets for $BRKR recently. We have seen 7 analysts offer price targets for $BRKR in the last 6 months, with a median target of $60.0.

Here are some recent targets:

Patrick Donnelly from Citigroup set a target price of $60.0 on 07/08/2026
Puneet Souda from Leerink Partners set a target price of $70.0 on 07/07/2026
Subbu Nambi from Guggenheim set a target price of $70.0 on 06/29/2026
Luke Sergott from Barclays set a target price of $60.0 on 06/24/2026
Casey Woodring from JP Morgan set a target price of $65.0 on 06/08/2026
Kyle Boucher from TD Cowen set a target price of $45.0 on 05/07/2026
Dan Leonard from UBS set a target price of $45.0 on 05/07/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.